Offer - Urjas Oil for just ₹ 1
Creon 10000 Capsule (10), a prescription drug, is manufactured in various forms such as Capsule. It is typically used for the treatment of Pancreatitis. Other than this, Creon 10000 Capsule (10) has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Creon 10000 Capsule (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Creon 10000 Capsule (10) are Blurred vision, Dry Mouth, Flushing. Besides the aforementioned side effects, there are other adverse effects of Creon 10000 Capsule (10) as well, which are listed below. Usually, these side effects of Creon 10000 Capsule (10) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Creon 10000 Capsule (10)'s effect during pregnancy is Moderate and Unknown while nursing. In addition, Creon 10000 Capsule (10)'s effects on the liver, heart and kidney are discussed below in the Creon 10000 Capsule (10) related warnings section.
The section on Creon 10000 Capsule (10) contraindications lists all such conditions.
Drug interactions for Creon 10000 Capsule (10) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Creon 10000 Capsule (10) is safe while driving, and is is addictive in nature.
Creon 10000 Capsule (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Creon 10000 Capsule (10) safe for pregnant women?
Creon may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Creon again without your doctor's advice.
Is the use of Creon 10000 Capsule (10) safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Creon for breastfeeding women are not known.
What is the effect of Creon 10000 Capsule (10) on the Kidneys?
Creon is completely safe for kidneys.
What is the effect of Creon 10000 Capsule (10) on the Liver?
Creon is completely safe for the liver.
What is the effect of Creon 10000 Capsule (10) on the Heart?
There are no any side effects of Creon for the heart.
If you are suffering from any of the following diseases, you should not take Creon 10000 Capsule (10) unless your doctor advises you to do so -
Is this Creon 10000 Capsule (10) habit forming or addictive?
Forming a habit of Creon 10000 Capsule (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Creon 10000 Capsule (10) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Creon 10000 Capsule (10) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Creon 10000 Capsule (10) is not used to treat mental disorders.
Interaction between Food and Creon 10000 Capsule (10)
It is safe to take Creon 10000 Capsule (10) with food.
Interaction between Alcohol and Creon 10000 Capsule (10)
No research has been done on this till date. Therefore, it is not known what the effect of taking Creon 10000 Capsule (10) with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Creon (pancrelipase)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 670